Share
The Health Resources and Services Administration is taking action against pharmaceutical manufacturers that refuse to provide rural healthcare providers with discounted prescription drugs.
Share
Congressman Morgan Griffith (R-VA) and bipartisan leaders of the House Energy and Commerce Committee sent letters to three leading drug manufacturers seeking answers and documents regarding their roles in the opioid crisis.
Share
U.S. Sen. Mark R. Warner is urging the GAO to look into private sector innovations related to outcome-based arrangements with drug manufacturers.
Share
Congressman Robert Hurt (R-Va.) introduced legislation along with Congressman Phil Roe (R-Tenn.) that would level the playing field for generic drug user fees so that smaller manufacturers would be expected to pay fees that would reflect the relative size of their firms compared to drug company giants.
Share
The bill that put a $35 monthly cap on insulin and allowed Medicare to negotiate the prices of other drugs turned two on Friday.
Share
No Tax Breaks for Drug Ads Act would prohibit pharmaceutical drug manufacturers from claiming tax deductions on advertising.
Share
A group of advocates met in Richmond today to call on Virginia Governor Glenn Youngkin to sign a bill to create a Prescription Drug Affordability Board.
Share
Insulin manufacturers Eli Lilly, Novo Nordisk and Sanofi have officially lowered the cost of their insulin products to $35 per month for most patients.
Share
The DRUG Act would disincentivize drug manufacturers and pharmacy benefit managers from raising drug prices for patients.
Share
Independent experts are concerned about the practice of using Pharmacy Benefit Managers (PBMs) with high prescription costs in the United States.
Augusta Free Press LLC | Privacy Policy
